Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01318707 · ClinicalTrials.gov registry record

Biomarkers Serum Collection Methodology Pilot Study

A clinical trial, sponsored by Georgetown University.

Completed
Registry status
20
Enrollment target

NCT01318707 is a clinical trial that has completed, run by Georgetown University. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01318707 has completed, sponsored by Georgetown University.

COMPLETED
Registry status
20 participants
Enrollment target

Study Summary

The purpose of this study is to compare the standard collection of whole blood in tiger top tubes for serum collection versus a collection method of added FVIII to whole blood samples in the hemophilia population for routine biomarker assays to ensure reliable assay results.

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2010-12
Est. Completion 2011-05

Sponsor

Georgetown University

227 total trials

What the Registry Record Tells You About NCT01318707

The ClinicalTrials.gov registry entry for NCT01318707 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01318707 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01318707 about?

NCT01318707 is a clinical study titled "Biomarkers Serum Collection Methodology Pilot Study". The purpose of this study is to compare the standard collection of whole blood in tiger top tubes for serum collection versus a collection method of added FVIII to whole blood samples in the hemophilia population for routine biomarker assays to ensure reliable assay results.

What is the current status of trial NCT01318707?

This trial is currently completed. The enrollment target is 20 participants. The study started on 2010-12. Estimated completion is 2011-05.

Who is sponsoring clinical trial NCT01318707?

This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.